Sign in

CIK 0001533040

  • Non-accelerated filer
  • Smaller reporting company

Phio Pharmaceuticals Corp.

Sign in to watch
Ticker
PHIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
453215903
Phone
+1 508-767-3861
Business address
411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
Former names
RXi Pharmaceuticals Corp
Open-market buys, last 90 days
$86,928
in 8 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$86,928. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-24 BRADFORD PATRICIA A Director Purchase +6,500 $1.01 $7K 64,151
2026-09-15 BRADFORD PATRICIA A Director Purchase +12,000 $1.03 $12K 57,651
2026-02-05 BRADFORD PATRICIA A Director Grant or award +18,500 45,651
2025-09-11 BRADFORD PATRICIA A Director Grant or award +18,800 27,151
2024-09-11 BRADFORD PATRICIA A Director Grant or award +8,000 8,000
2023-02-17 BRADFORD PATRICIA A Director Grant or award +1,500 3,167
2022-08-09 BRADFORD PATRICIA A Director Grant or award +20,000 20,000

Page 1 of 1 · 7 trades